Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
JNJ · against 553 other Healthcare companies listed in US-listed
Ranked #114 of 554 · scores higher than 79% of peers
Bars: peers in each 10-point band of the overall score92 peers with an overall score of 50–59, including JNJ · Click a bar to see the companies
| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 658M USD | 97 | 96 | 98 | 99 | 0 / 2 | |
| 1 | 2.0B USD | 97 | 97 | 99 | 93 | 0 / 2 | |
| 1 | 238M USD | 97 | 94 | — | 98 | 0 / 2 | |
| 4 | 1.5B USD | 93 | 94 | 91 | 93 | 0 / 2 | |
| 5 | 658M USD | 91 | 94 | 100 | 99 | 0 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 109 | 12.6B USD | 60 | 56 | 80 | 95 | 2 / 2 |
| 109 | 20.4B USD | 60 | 68 | 56 | 79 | 1 / 2 |
| 109 | 20.9B USD | 60 | 95 | 53 | 90 | 2 / 2 |
| 114 | 12.1B USD | 59 | 76 | 58 | 84 | 2 / 2 |
| 114 | 622.8B USD | 59 | 60 | 48 | 91 | 1 / 2 |
| 114 | 506M USD | 59 | 78 | 18 | 90 | 1 / 2 |
| 114 | 1.1B USD | 59 | 47 | 88 | 44 | 1 / 2 |
| 114 | 29.6B USD | 59 | 88 | 42 | 95 | 2 / 2 |
| 119 | 481M USD | 58 | 52 | 78 | 36 | 0 / 2 |